ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P46-25 New Medical and Behavioral Health Policy Management Updates, Effective October 6, 2025
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါအီကူာ် 01, 2025
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 601 - 610 လၢ 4351 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP60-25 MHCP Pharmacy Benefit Exclusion for Emrelis™, Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယူၤလံ 09, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP59-25 Commercial Pharmacy Benefit Exclusion for Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယူၤလံ 09, 2025